Status:
UNKNOWN
Echocardiographic Assessment and CLInical imPlication of Functional tricuSpid rEgurgitation in Heart Failure With Reduced or Preserved Ejection Fraction
Lead Sponsor:
Fondazione IRCCS Policlinico San Matteo di Pavia
Collaborating Sponsors:
Cardarelli Hospital
Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy
Conditions:
Functional Tricuspid Regurgitation
Eligibility:
All Genders
18+ years
Brief Summary
Purpose Functional tricuspid regurgitation (FTR) has been shown to be associated with increased morbidity and mortality in several clinical conditions, including heart failure (HF) with reduced left v...
Eligibility Criteria
Inclusion
- consecutive consenting outpatients with HFrEF, HFmrHF, HFpEF or PAH,
- ambulatory visit routinely planned with an echocardiographic examination,
- at the time of the visit at least moderate FTR diagnosed at echocardiography (by visual assessment),
- aged ≥ 18 years old,
- capable to sign an informed consent.
Exclusion
- age \< 18 years old,
- congenital heart disease,
- heart failure due to organic mitral or aortic valve disease. No examination will be performed in addition to what is routinely planned for patients' evaluation.
Key Trial Info
Start Date :
November 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05209919
Start Date
November 11 2021
End Date
December 1 2024
Last Update
January 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Foundation IRCCS SanMatteo Hospital
Pavia, PV, Italy, 27100